A randomised double-blind placebo controlled trial of the effectiveness of the beta-blocker bisoprolol in preventing exacerbations of chronic obstructive pulmonary disease.
|PI Name||Gompertz - S|
|Speciality||Lung Investigation Unit|
|Sponsor||University of Aberdeen|
|Proposed End Date||31/01/2023|
|Study Run through CRF?||Yes|
|Target number of patients agreed to recruit||60|
|Recruitment so far||6|